Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

P-gp

  • You have access
    A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells
    CHUNXUE JIANG, SU HYUN LEE, JAE HYEON PARK, JIN-SOL LEE, JI WON PARK, JU RI KIM, SONG HEE LEE, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research February 2021, 41 (2) 687-697; DOI: https://doi.org/10.21873/anticanres.14820
  • You have access
    Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition
    JI YEONG KIM, YOO JUNG PARK, BYUNG-MU LEE and SUNGPIL YOON
    Anticancer Research July 2019, 39 (7) 3757-3765; DOI: https://doi.org/10.21873/anticanres.13524
  • You have access
    Histamine Receptor Antagonists, Loratadine and Azelastine, Sensitize P-gp-overexpressing Antimitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms
    JI YEONG KIM, KYEONG SEOK KIM, IN SU KIM and SUNGPIL YOON
    Anticancer Research July 2019, 39 (7) 3767-3775; DOI: https://doi.org/10.21873/anticanres.13525
  • You have access
    Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp
    JI YEONG KIM, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research July 2019, 39 (7) 3785-3793; DOI: https://doi.org/10.21873/anticanres.13527
  • You have access
    P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells
    JI YEONG KIM, YUJIN PARK, BYUNG-MU LEE, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research October 2018, 38 (10) 5685-5692; DOI: https://doi.org/10.21873/anticanres.12905
  • You have access
    Low Doses of the Anti-psychotic Drug Aripiprazole Have Strong P-gp-inhibitory Activity and Sensitize Anti-mitotic Drug-resistant Cancer Cells
    JI YEONG KIM, IN HWAN TAE, BYUNG-MU LEE, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research September 2018, 38 (9) 5101-5108; DOI: https://doi.org/10.21873/anticanres.12830
  • You have access
    Aging-related Repositioned Drugs, Donepezil and Sildenafil Citrate, Increase Apoptosis of Anti-mitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms
    JI YEONG KIM, JI YEON SON, BYUNG-MU LEE, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research September 2018, 38 (9) 5149-5157; DOI: https://doi.org/10.21873/anticanres.12837
  • You have access
    P-gp Inhibition by XL019, a JAK2 Inhibitor, Increases Apoptosis of Vincristine-treated Resistant KBV20C Cells with Increased p21 and pH2AX Expression
    JI HYUN CHEON, JI YEONG KIM, BYUNG-MU LEE, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research December 2017, 37 (12) 6761-6769;
  • You have access
    Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes
    SILVIA ANGELINI, ANDREA BOTTICELLI, CONCETTA ELISA ONESTI, RAFFAELE GIUSTI, VALENTINA SINI, VALERIA DURANTE, LIDIA STRIGARI, GIOVANNA GENTILE, BRUNA CERBELLI, PATRIZIA PELLEGRINI, VALENTINA SGROI, MARIO OCCHIPINTI, FRANCESCA ROMANA DI PIETRO, ALESSANDRO ROSSI, MAURIZIO SIMMACO, FEDERICA MAZZUCA and PAOLO MARCHETTI
    Anticancer Research May 2017, 37 (5) 2633-2639;
  • You have access
    Attenuation of Colchicine Toxicity in Drug-resistant Cancer Cells by Co-treatment with Anti-malarial Drugs
    AE-RAN CHOI, JU-HWA KIM, JI HYUN CHEON, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research November 2016, 36 (11) 5859-5866;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire